What Has Been the Growth of the Infusion Pump Market So Far?
The infusion pump market has seen considerable growth due to a variety of factors.
• Over the past few years, the infusion pump market has seen robust growth. Projected growth for the market is from $14.77 billion in 2024 to $15.85 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.4%. The previous period's growth can be traced back to factors such as an aging population, increased instances of chronic diseases, trends in hospitalization, surgical procedures, and advancements in the healthcare sector.
What Is the Forecasted Market Size and Growth Rate for The Infusion Pump Market?
The Infusion Pump market is expected to maintain its strong growth trajectory in upcoming years.
• It is anticipated that the infusion pump market will experience robust growth in the coming years, expanding to $22.92 billion by 2029 with a compound annual growth rate (CAGR) of 9.7%.
Contributing factors to this predicted growth encompass the increase in home healthcare, the growth of ambulatory care centers, worldwide health issues, advancements in technology, and patient empowerment. Forecasted trends include the creation of wearable infusion devices, the extension of ambulatory infusion facilities, the adaptation to pediatric and geriatric patients, a focus on cost-effectiveness and efficiency, and the incorporation of artificial intelligence in infusion systems.
What Factors Are Driving Growth In The Infusion Pump Market?
The infusion pump market is poised for growth, driven by the increasing prevalence of chronic diseases. Chronic or noncommunicable diseases (NCDs) are long-term health issues that typically develop slowly over a prolonged period. This increase in chronic conditions such as cancer and diabetes can be attributed to shifting lifestyles, sedentary behavior, declining quality of life, and unhealthy diet. Infusion pumps play a crucial role in managing such diseases by ensuring precise dosing, accurate fluid delivery, and personalized treatment options. The National Center for Biotechnology Information (NCBI), a part of the US-based National Library of Medicine, predicted in January 2023, that the number of individuals with chronic diseases around the world will reach 142.66 million by 2050, significantly up from the 71.522 million recorded in 2020. Furthermore, the International Diabetes Federation, which comprises over 230 national diabetes associations from more than 160 countries, forecasts the global diabetic population to expand to 643 million by 2030 and to 783 million by 2045. Consequently, the increase in chronic disease prevalence is expected to boost the expansion of the infusion pump market.
What Are The Main Segments Of The Global Infusion Pump Market?
The infusion pump market covered in this report is segmented –
1) By Product: Accessories And Consumables, Devices
2) By Type: Volumetric Infusion Pumps, Insulin Pumps, Enteral Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, PCA Pumps, Implantable Infusion Pumps
3) By Technology: Traditional Infusion Pumps, Specialty Infusion Pumps
4) By Application: Chemotherapy Or Oncology, Diabetes Management, Gastroenterology, Pain Management Or Analgesia, Pediatrics Or Neonatology, Hematology, Other Applications
5) By End User: Hospitals, Ambulatory Care Settings, Specialty Clinics, Home Care Settings
Subsegments:
1) By Accessories And Consumables: Infusion Sets, IV Catheters, Syringes, Safety Needles, Tubing
2) By Devices: Volumetric Infusion Pumps, Syringe Pumps, Ambulatory Infusion Pumps, PCA (Patient-Controlled Analgesia) Pumps, Insulin Pumps, Enteral Infusion Pumps
Pre-Book The Infusion Pump Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Infusion Pump Market?
The rise in technological innovations is increasingly shaping the infusion pump market, becoming a significant trend. Key players in this market are striving to invent new technical solutions to solidify their market standing. For instance, in November 2022, Medtronic, a leading American medical device company, unveiled the MiniMed Quick-set Plus - the world's foremost and exclusive insulin pump infusion set. With its state-of-the-art components, it helps reduce insulin preservative loss and ensures the steady flow and stability of insulin and doubles the lifespan of the customary infusion set's wear time. This FDA-approved infusion set is noted for its uniqueness and is designed to offer diabetic patients a more user-friendly and comfortable experience.
Who Are the Key Players In The Infusion Pump Market?
Major companies operating in the infusion pump market include:
• Becton Dickinson and Company
• Baxter International Inc.
• B. Braun Melsungen AG
• ICU Medical Inc.
• Fresenius Kabi AG
• Smiths Medical Inc.
• Medtronic plc
• Moog Inc.
• Terumo Corporation
• Insulet Corporation
• Boston Scientific Corporation
• Tandem Diabetes Care Inc.
• InfuTronix Solutions LLC
• Micrel Medical Devices SA
• Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
• Mindray Medical International Limited
• Caesarea Medical Electronics Ltd.
• Hospitech Respiration Ltd.
• IRadimed Corporation
• Ivenix Inc.
• Sooil Development Co. Ltd.
• ZOLL Medical Corporation
• Zyno Medical LLC
What Is The Most Dominant Region In The Infusion Pump Market?
North America was the largest region in the infusion pump market in 2024. The regions covered in the infusion pump market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
